Skip to main content
SpringerLink
Log in

Muscarinics for Xerostomia in Patients with Sjögren’s Syndrome

  • Correspondence
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yasuda H, Niki H. Review of the pharmacological properties and clinical usefulness of muscarinic agonists for xerostomia in patients with Sjögren’s syndrome. Clin Drug Invest 2002; 22: 67–73

    Article  CAS  Google Scholar 

  2. Ferguson MM. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1993; 75: 186–91

    Article  PubMed  CAS  Google Scholar 

  3. Smirk FH. Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene l:5-bis-N (N-methyl pyrrolidinium) bitartrate (M&B 2050). N Z Med J 1953; 52: 325–48

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Otago, Dunedin, New Zealand

    Martin M. Ferguson

Authors
  1. Martin M. Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferguson, M.M. Muscarinics for Xerostomia in Patients with Sjögren’s Syndrome. Clin. Drug Investig. 22, 639–640 (2002). https://doi.org/10.2165/00044011-200222090-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200222090-00010

Keywords

Search

Navigation